Cystic fibrosis (CF) is an inherited disorder with a devastating prognosis. Determination of chloride concentration in sweat has been the gold standard test for diagnosing CF for over 50 years and still remains the primary screening test. However, now that the genetic cause is known and can be studied, genetic confirmation is mandatory in every suspected patient. We present a patient who had been clinically diagnosed and whose genetic testing could not confirm CF, leading us to search for other options that may also give a positive sweat test. The patient turned out to suffer type 1 pseudohypoaldosteronism, a condition that may cause severe dehydration, hyponatremia and hyperkalemia episodes if not diagnosed and treated early with sodium supplementation. We found a genetic variation in the epithelial sodium channel gene which has not been reported previously, and we discuss the possibility of it being the cause of our patient’s phenotype. Conclusion: this patient clearly illustrates the usefulness of genetic confirmation for CF for the diagnosis and genetic counselling, even when it is clinically oriented, and describes a novel mutation of the amiloride-sensitive epithelial sodium channel possibly causing type 1 pseudohypoaldosteronism.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Pseudohypoaldosteronism type 1
Epithelial sodium channel
Denaturing gradient gel electrophoresis
Single-stranded conformation polymorphism/heteroduplex
Polymerase chain reaction
Restriction fragment length polymorphism
Azad AK, Rauh R, Vermeulen F, Jaspers M, Korbmacher J, Boissier B, Bassinet L et al (2009) Mutations in the amiloride-sensitive epithelial sodium channel in patients with cystic fibrosis-like disease. Hum Mutat 30:1093–1103
Berdiev BK, Qadri YJ, Benos DJ (2009) Assessment of the CFTR and ENaC association. Mol Biosyst 5:123–127
Fajac I, Viel M, Gaitch N, Hubert D, Bienvenu T (2009) Combination of ENaC and CFTR mutations may predispose to cystic fibrosis-like disease. Eur Respir J 34:772–773
Hanukoglu A, Bistritzer T, Rakover Y, Mandelberg A (1994) Pseudohypoaldosteronism with increased sweat and saliva electrolyte values and frequent lower respiratory tract infections mimicking cystic fibrosis. J Pediatr 125:752–755
Kashlan OB, Maarouf AB, Kussius C, Denshaw RM, Blumenthal KM, Kleyman TR (2006) Distinct structural elements in the first membrane-spanning segment of the epithelial sodium channel. J Biol Chem 281:30455–30462
Noone PG, Pue CA, Zhou Z, Friedman KJ, Wakeling EL, Ganeshananthan M, Simon RH, Silverman LM, Knowles MR (2000) Lung disease associated with the IVS8 5T allele of the CFTR gene. Am J Respir Crit Care Med 162:1919–1924
Rauh R, Diakov A, Tzschoppe A, Korbmacher J, Azad AK, Cuppens H, Cassiman JJ, Dotsch J, Sticht H, Korbmacher C (2010) A mutation of the epithelial sodium channel associated with atypical cystic fibrosis increases channel open probability and reduces Na+ self inhibition. J Physiol 588:1211–1225
Sheridan MB, Fong P, Groman JD, Conrad C, Flume P, Diaz R, Harris C, Knowles M, Cutting GR (2005) Mutations in the beta-subunit of the epithelial Na+ channel in patients with a cystic fibrosis-like syndrome. Hum Mol Genet 14:3493–3498
Wallis C (2003) Atypical cystic fibrosis—diagnostic and management dilemmas. J R Soc Med 96(Suppl 43):2–10
Weiss FU, Simon P, Bogdanova N, Mayerle J, Dworniczak B, Horst J et al (2005) Complete cystic fibrosis transmembrane conductance regulator gene sequencing in patients with idiopathic chronic pancreatitis and controls. Gut 54(10):1456–1460
About this article
Cite this article
Mora-Lopez, F., Bernal-Quiros, M., Lechuga-Sancho, A.M. et al. Novel mutation in the epithelial sodium channel causing type I pseudohypoaldosteronism in a patient misdiagnosed with cystic fibrosis. Eur J Pediatr 171, 997–1000 (2012). https://doi.org/10.1007/s00431-012-1697-5
- Cystic fibrosis
- Type I pseudohypoaldosteronism
- Epithelial sodium channel